Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Ear and labyrinth disorders – page 2

  • 37 clinical trials
  • 14 recruiting
  • 43 conditions
  • 18 countries

Conditions in this area

43 conditions with trials, the busiest first

Deafness8Alport's syndrome6Paraganglion neoplasm5Deafness neurosensory4Phaeochromocytoma4Otitis media3Vestibular disorder3Focal segmental glomerulosclerosis2Meniere's disease2Neuroendocrine tumour2Tinnitus2Usher's syndrome2Wolfram syndrome2Acoustic neuroma1Bile duct cancer1Chronic kidney disease1Chronic rhinosinusitis with nasal polyps1Colorectal cancer1Deafness bilateral1Deafness traumatic1Dizziness1Ductal adenocarcinoma of pancreas1Ear discomfort1Endolymphatic hydrops1+19

Clinical trials in Ear and labyrinth disorders

37 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

37 clinical trials

Deafness neurosensory

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Nitrous Oxide
  • Sponsor:Helse Bergen HF

Meniere's disease

Recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Betahistine Dihydrochloride
  • Sponsor:Intas Pharmaceuticals Limited

Deafness

Not yet recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Sponsor:Sensorion

Paraganglion neoplasm+1

Not yet recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Assistance Publique Hopitaux De Paris

Otitis media chronic

Not yet recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ciprofloxacin
  • Sponsor:Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre

Otitis media

Not yet recruiting
Registered drug
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Pohjois-Savon hyvinvointialue

Deafness

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Assistance Publique Hopitaux De Paris

Paraganglion neoplasm+2

Not yet recruiting
InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177Lu) Edotreotide
  • Sponsor:Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.

Deafness

Not yet recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Aavanc80-3'Hotof
  • Sponsor:Akouos Inc.

Chronic kidney disease+1

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Bayer AG

Prophylaxis against motion sickness+1

Not recruiting
Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · Healthy volunteers
  • Substances:DIMENHYDRINATE
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG

Wolfram syndrome

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tirzepatide
  • Sponsor:Ospedale San Raffaele S.r.l.

Substances studied in this area

The therapies tested most often in Ear and labyrinth disorders trials.

Prednisolone3 clinical trialsAavanc80-3'Hotof2 clinical trialsAavanc80-5'Hotof2 clinical trialsOxygen2 clinical trialsPlacebo2 clinical trialsSodium Chloride2 clinical trialsTriamcinolone Acetonide2 clinical trials6-Fluoro-9-Methyl-9H-Pyrido[3,4-B]-Indole1 clinical trialAbiraterone Acetate1 clinical trial
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.